GA HR1350

Georgia House Resolution urging the President and Congress to require the FDA to establish Good Manufacturing Practice (GMP) standards for industrial hemp products with THC content below 0.3 percent and to set a safe daily level of CBD consumption for consumers

Notes that over 1,500 CBD products have entered the market without clear FDA regulation, despite the 2018 Farm Bill removing hemp (below 0.3% THC) from the federal Controlled Substances Act

Highlights that the FDA considers CBD food additives and dietary supplements illegal under federal law while refusing to issue manufacturing regulations, creating a patchwork of inconsistent state-level rules that puts consumers at health risk

Cites impaired interstate commerce for CBD companies because banks, insurance companies, and merchant service providers refuse services due to reputational risks stemming from FDA's threatened regulatory actions

Directs the Clerk of the Georgia House to distribute copies of the resolution to the President, Vice President, congressional leadership, and all U.S. Congress members elected from Georgia